Mammogen Information

We are a predictive health company developing RNA-powered molecular diagnostics designed to detect real-time biological signals of disease earlier and with greater accessibility across the landscape of women’s health, starting with breast cancer. Our lead product, genTRU-breast™, is a blood-based assay being developed to provide a real-time biologic signal that could complement imaging and support breast cancer detection, particularly in women with dense breast tissue. With a platform built on scalable RNA biomarker discovery and computational interpretation, our pipeline is designed to expand into additional women’s health applications over time.